Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?

Tytuł:
Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?
Autorzy:
Roger-Rollé A; Cardiology, Rangueil University Hospital, Toulouse, France.; Cardiac Imaging Center, University Hospital of Toulouse, Toulouse, France.
Cariou E; Cardiology, Rangueil University Hospital, Toulouse, France.; Cardiac Imaging Center, University Hospital of Toulouse, Toulouse, France.
Rguez K; Cardiology, Rangueil University Hospital, Toulouse, France.; Cardiac Imaging Center, University Hospital of Toulouse, Toulouse, France.
Fournier P; Cardiology, Rangueil University Hospital, Toulouse, France.; Cardiac Imaging Center, University Hospital of Toulouse, Toulouse, France.
Lavie-Badie Y; Cardiology, Rangueil University Hospital, Toulouse, France.; Cardiac Imaging Center, University Hospital of Toulouse, Toulouse, France.; Department of Nuclear Medicine, University Hospital of Toulouse, Toulouse, France.
Blanchard V; Cardiology, Rangueil University Hospital, Toulouse, France.; Cardiac Imaging Center, University Hospital of Toulouse, Toulouse, France.; Department of Nuclear Medicine, University Hospital of Toulouse, Toulouse, France.; Medical School, Toulouse III Paul Sabatier University, Toulouse, France.
Roncalli J; Cardiology, Rangueil University Hospital, Toulouse, France.; Medical School, Toulouse III Paul Sabatier University, Toulouse, France.
Galinier M; Cardiology, Rangueil University Hospital, Toulouse, France.; Cardiac Imaging Center, University Hospital of Toulouse, Toulouse, France.; Medical School, Toulouse III Paul Sabatier University, Toulouse, France.
Carrié D; Cardiology, Rangueil University Hospital, Toulouse, France.; Cardiac Imaging Center, University Hospital of Toulouse, Toulouse, France.; Medical School, Toulouse III Paul Sabatier University, Toulouse, France.
Lairez O; Cardiology, Rangueil University Hospital, Toulouse, France .; Cardiac Imaging Center, University Hospital of Toulouse, Toulouse, France.; Department of Nuclear Medicine, University Hospital of Toulouse, Toulouse, France.; Medical School, Toulouse III Paul Sabatier University, Toulouse, France.
Corporate Authors:
Toulouse Amyloidosis Research Network collaborators
Źródło:
Open heart [Open Heart] 2020 Oct; Vol. 7 (2).
Typ publikacji:
Comparative Study; Journal Article
Język:
English
Imprint Name(s):
Original Publication: [London] : BMJ Publishing Group
MeSH Terms:
Echocardiography, Doppler*
Echocardiography, Stress*
Exercise Test*
Myocardial Contraction*
Stroke Volume*
Ventricular Function, Left*
Amyloidosis/*diagnostic imaging
Cardiomyopathies/*diagnostic imaging
Aged ; Aged, 80 and over ; Amyloidosis/mortality ; Amyloidosis/physiopathology ; Cardiomyopathies/mortality ; Cardiomyopathies/physiopathology ; Female ; Humans ; Male ; Middle Aged ; Observer Variation ; Predictive Value of Tests ; Prognosis ; Reproducibility of Results ; Retrospective Studies
References:
Eur J Echocardiogr. 2009 Dec;10(8):914-21. (PMID: 19666722)
Eur Heart J Cardiovasc Imaging. 2020 Jun 12;:. (PMID: 32529207)
J Am Coll Cardiol. 2016 Sep 6;68(10):1014-20. (PMID: 27585505)
Amyloid. 2015 Mar;22(1):61-6. (PMID: 25510353)
Heart. 2012 Oct;98(19):1442-8. (PMID: 22865865)
Echocardiography. 2019 Jan;36(1):74-82. (PMID: 30488501)
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70. (PMID: 25712077)
Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):1-11. (PMID: 25525063)
J Am Coll Cardiol. 2018 May 8;71(18):1947-1957. (PMID: 29724346)
J Am Soc Echocardiogr. 2013 Feb;26(2):185-91. (PMID: 23218891)
Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1321-1360. (PMID: 27422899)
Eur J Heart Fail. 2007 Jun-Jul;9(6-7):617-24. (PMID: 17350331)
Circulation. 2009 Sep 29;120(13):1203-12. (PMID: 19752327)
J Card Fail. 2018 Aug;24(8):504-511. (PMID: 30010028)
Eur Heart J Cardiovasc Imaging. 2019 May 1;20(5):582-590. (PMID: 30590562)
J Am Soc Echocardiogr. 2019 Aug;32(8):947-957. (PMID: 31043359)
Circulation. 2016 Jun 14;133(24):2404-12. (PMID: 27143678)
JACC Cardiovasc Imaging. 2009 Dec;2(12):1369-77. (PMID: 20083070)
Clin Res Cardiol. 2020 Jan;109(1):78-88. (PMID: 31134330)
Eur Heart J Cardiovasc Imaging. 2019 Jan 1;20(1):31-39. (PMID: 30247622)
J Am Coll Cardiol. 2002 Jul 17;40(2):325-9. (PMID: 12106939)
Circ J. 2011;75(5):1200-8. (PMID: 21427499)
Curr Cardiol Rev. 2017;13(1):32-40. (PMID: 27411342)
Circ Cardiovasc Imaging. 2018 May;11(5):e006588. (PMID: 29752392)
Eur J Intern Med. 2020 Oct;80:66-72. (PMID: 32475765)
Trends Cardiovasc Med. 2018 Jan;28(1):10-21. (PMID: 28739313)
J Am Coll Cardiol. 2012 Sep 18;60(12):1067-76. (PMID: 22883634)
Eur Heart J. 2012 Mar;33(6):724-33. (PMID: 22315346)
Eur Heart J. 2018 Aug 7;39(30):2799-2806. (PMID: 29048471)
J Am Coll Cardiol. 2005 Sep 20;46(6):1076-84. (PMID: 16168294)
Contributed Indexing:
Keywords: echocardiography; heart failure with preserved ejection fraction; restrictive cardiomyopathy
Entry Date(s):
Date Created: 20201014 Date Completed: 20201222 Latest Revision: 20201222
Update Code:
20240105
PubMed Central ID:
PMC7555098
DOI:
10.1136/openhrt-2020-001346
PMID:
33051335
Czasopismo naukowe
Background: Cardiac amyloidosis (CA) is a life-threatening restrictive cardiomyopathy. Identifying patients with a poor prognosis is essential to ensure appropriate care. The aim of this study was to compare myocardial work (MW) indices with standard echocardiographic parameters in predicting mortality among patients with CA.
Methods: Clinical, biological and transthoracic echocardiographic parameters were retrospectively compared among 118 patients with CA. Global work index (GWI) was calculated as the area of left ventricular pressure-strain loop. Global work efficiency (GWE) was defined as percentage ratio of constructive work to sum of constructive and wasted works. Sixty-one (52%) patients performed a cardiopulmonary exercise.
Results: GWI, GWE, global longitudinal strain (GLS), left ventricular ejection fraction (LVEF) and myocardial contraction fraction (MCF) were correlated with N-terminal prohormone brain natriuretic peptide (R=-0.518, R=-0.383, R=-0.553, R=-0.382 and R=-0.336, respectively; p<0.001). GWI and GLS were correlated with peak oxygen consumption (R=0.359 and R=0.313, respectively; p<0.05). Twenty-eight (24%) patients died during a median follow-up of 11 (4-19) months. The best cut-off values to predict all-cause mortality for GWI, GWE, GLS, LVEF and MCF were 937 mm Hg/%, 89%, 10%, 52% and 15%, respectively. The area under the receiver operator characteristic curve of GWE, GLS, GWI, LVEF and MCF were 0.689, 0.631, 0.626, 0.511 and 0.504, respectively.
Conclusion: In CA population, MW indices are well correlated with known prognosis markers and are better than LVEF and MCF in predicting mortality. However, MW does not perform better than GLS.
Competing Interests: Competing interests: None declared.
(© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies